tiprankstipranks
Xencor Inc. (XNCR)
NASDAQ:XNCR
US Market
XNCR
Xencor
RESEARCH TOOLSreports
Want to see XNCR full AI Analyst Report?

Xencor (XNCR) Stock Forecast & Price Target

354 Followers
See the Price Targets and Ratings of:

XNCR Analyst Ratings

Strong Buy
11Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Xencor
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

XNCR Stock 12 Month Forecast

Average Price Target

$24.30
▲(86.06% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Xencor in the last 3 months. The average price target is $24.30 with a high forecast of $38.00 and a low forecast of $13.00. The average price target represents a 86.06% change from the last price of $13.06.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","39":"$39","14.25":"$14.25","22.5":"$22.5","30.75":"$30.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$38.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,14.25,22.5,30.75,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.69,14.636923076923077,16.583846153846153,18.53076923076923,20.47769230769231,22.424615384615386,24.371538461538464,26.31846153846154,28.26538461538462,30.212307692307697,32.159230769230774,34.10615384615385,36.05307692307692,{"y":38,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.69,13.583076923076923,14.476153846153846,15.36923076923077,16.262307692307694,17.155384615384616,18.048461538461538,18.941538461538464,19.834615384615386,20.72769230769231,21.620769230769234,22.513846153846153,23.40692307692308,{"y":24.3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.69,12.713846153846154,12.737692307692308,12.76153846153846,12.785384615384615,12.80923076923077,12.833076923076923,12.856923076923076,12.88076923076923,12.904615384615385,12.928461538461539,12.952307692307691,12.976153846153846,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.86,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.58,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.07,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.98,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.55,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.83,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.71,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.51,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.31,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.11,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.3,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.53,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.69,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$38.00Average Price Target$24.30Lowest Price Target$13.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on XNCR
Alec Stranahan
Bank of America Securities
Bank of America Securities
$17
Hold
30.17%
Upside
Reiterated
05/13/26
Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR)
TD Cowen Analyst forecast on XNCR
Tara Bancroft
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/11/26
Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (NYSE: DNA), Xencor (NASDAQ: XNCR) and Alto Neuroscience, Inc. (NYSE: ANRO)
J.P. Morgan Analyst forecast on XNCR
Brian Cheng
J.P. Morgan
J.P. Morgan
$13→$14
Hold
7.20%
Upside
Assigned
05/11/26
Xencor price target raised to $14 from $13 at JPMorganXencor price target raised to $14 from $13 at JPMorgan
Piper Sandler Analyst forecast on XNCR
Edward Tenthoff
Piper Sandler
Piper Sandler
$33
Buy
152.68%
Upside
Reiterated
05/08/26
Piper Sandler Reaffirms Their Buy Rating on Xencor (XNCR)
Wells Fargo Analyst forecast on XNCR
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$27
Buy
106.74%
Upside
Reiterated
05/07/26
Xencor (XNCR) Receives a Buy from Wells Fargo
Wedbush Analyst forecast on XNCR
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$26
Buy
99.08%
Upside
Reiterated
05/07/26
Wedbush Remains a Buy on Xencor (XNCR)
Barclays Analyst forecast on XNCR
Etzer Darout
Barclays
Barclays
$27
Buy
106.74%
Upside
Assigned
05/07/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Xencor (NASDAQ: XNCR), Inspire Medical Systems (NYSE: INSP) and Amgen (NASDAQ: AMGN)
Truist Financial Analyst forecast on XNCR
Gregory Renza
Truist Financial
Truist Financial
$29
Buy
122.05%
Upside
Reiterated
05/07/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), DENTSPLY SIRONA (NASDAQ: XRAY) and Neurocrine (NASDAQ: NBIX)
William Blair Analyst forecast on XNCR
Matt Phipps
William Blair
William Blair
$13
Buy
-0.46%
Downside
Reiterated
05/06/26
Buy Rating on Xencor as TL1A Franchise Data and Upcoming Phase IIb Catalyst Support Upside Potential
Canaccord Genuity Analyst forecast on XNCR
John Newman
Canaccord Genuity
Canaccord Genuity
$38
Buy
190.96%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), Oscar Health (NYSE: OSCR) and REPRO-MED Systems (NASDAQ: KRMD)
RBC Capital Analyst forecast on XNCR
Leonid Timashev
RBC Capital
RBC Capital
$19
Buy
45.48%
Upside
Reiterated
05/05/26
Analysts' Top Healthcare Picks: Xencor (XNCR), Rhythm Pharmaceuticals (RYTM)
Cantor Fitzgerald Analyst forecast on XNCR
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$43
Buy
229.25%
Upside
Reiterated
02/25/26
Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Xencor (NASDAQ: XNCR) and Pennant Group (NASDAQ: PNTG)
Roth MKM Analyst forecast on XNCR
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
$6
Sell
-54.06%
Downside
Initiated
09/17/25
Xencor (XNCR) Receives a Sell from Roth MKM
Raymond James Analyst forecast on XNCR
Sean McCutcheon
Raymond James
Raymond James
$40
Buy
206.28%
Upside
Reiterated
08/07/25
Leerink Partners Analyst forecast on XNCR
Jonathan Chang
Leerink Partners
Leerink Partners
$27
Buy
106.74%
Upside
Reiterated
08/07/25
Xencor (XNCR) Receives a Buy from Leerink Partners
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on XNCR
Alec Stranahan
Bank of America Securities
Bank of America Securities
$17
Hold
30.17%
Upside
Reiterated
05/13/26
Bank of America Securities Sticks to Their Hold Rating for Xencor (XNCR)
TD Cowen Analyst forecast on XNCR
Tara Bancroft
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/11/26
Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (NYSE: DNA), Xencor (NASDAQ: XNCR) and Alto Neuroscience, Inc. (NYSE: ANRO)
J.P. Morgan Analyst forecast on XNCR
Brian Cheng
J.P. Morgan
J.P. Morgan
$13→$14
Hold
7.20%
Upside
Assigned
05/11/26
Xencor price target raised to $14 from $13 at JPMorganXencor price target raised to $14 from $13 at JPMorgan
Piper Sandler Analyst forecast on XNCR
Edward Tenthoff
Piper Sandler
Piper Sandler
$33
Buy
152.68%
Upside
Reiterated
05/08/26
Piper Sandler Reaffirms Their Buy Rating on Xencor (XNCR)
Wells Fargo Analyst forecast on XNCR
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$27
Buy
106.74%
Upside
Reiterated
05/07/26
Xencor (XNCR) Receives a Buy from Wells Fargo
Wedbush Analyst forecast on XNCR
Unknown Analyst
Wedbush
Not Ranked
Wedbush
$26
Buy
99.08%
Upside
Reiterated
05/07/26
Wedbush Remains a Buy on Xencor (XNCR)
Barclays Analyst forecast on XNCR
Etzer Darout
Barclays
Barclays
$27
Buy
106.74%
Upside
Assigned
05/07/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Xencor (NASDAQ: XNCR), Inspire Medical Systems (NYSE: INSP) and Amgen (NASDAQ: AMGN)
Truist Financial Analyst forecast on XNCR
Gregory Renza
Truist Financial
Truist Financial
$29
Buy
122.05%
Upside
Reiterated
05/07/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), DENTSPLY SIRONA (NASDAQ: XRAY) and Neurocrine (NASDAQ: NBIX)
William Blair Analyst forecast on XNCR
Matt Phipps
William Blair
William Blair
$13
Buy
-0.46%
Downside
Reiterated
05/06/26
Buy Rating on Xencor as TL1A Franchise Data and Upcoming Phase IIb Catalyst Support Upside Potential
Canaccord Genuity Analyst forecast on XNCR
John Newman
Canaccord Genuity
Canaccord Genuity
$38
Buy
190.96%
Upside
Reiterated
05/06/26
Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR), Oscar Health (NYSE: OSCR) and REPRO-MED Systems (NASDAQ: KRMD)
RBC Capital Analyst forecast on XNCR
Leonid Timashev
RBC Capital
RBC Capital
$19
Buy
45.48%
Upside
Reiterated
05/05/26
Analysts' Top Healthcare Picks: Xencor (XNCR), Rhythm Pharmaceuticals (RYTM)
Cantor Fitzgerald Analyst forecast on XNCR
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$43
Buy
229.25%
Upside
Reiterated
02/25/26
Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Xencor (NASDAQ: XNCR) and Pennant Group (NASDAQ: PNTG)
Roth MKM Analyst forecast on XNCR
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
$6
Sell
-54.06%
Downside
Initiated
09/17/25
Xencor (XNCR) Receives a Sell from Roth MKM
Raymond James Analyst forecast on XNCR
Sean McCutcheon
Raymond James
Raymond James
$40
Buy
206.28%
Upside
Reiterated
08/07/25
Leerink Partners Analyst forecast on XNCR
Jonathan Chang
Leerink Partners
Leerink Partners
$27
Buy
106.74%
Upside
Reiterated
08/07/25
Xencor (XNCR) Receives a Buy from Leerink Partners
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Xencor

3 Months
David NierengartenWedbush
Success Rate
6/11 ratings generated profit
55%
Average Return
+14.36%
Copying David Nierengarten's trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +14.36% per trade.
1 Year
John NewmanCanaccord Genuity
Success Rate
4/11 ratings generated profit
36%
Average Return
-5.70%
Copying John Newman's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of -5.70% per trade.
2 Years
Edward TenthoffPiper Sandler
Success Rate
4/12 ratings generated profit
33%
Average Return
-3.62%
Copying Edward Tenthoff's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -3.62% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XNCR Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
6
9
10
9
9
Buy
7
6
7
5
5
Hold
2
2
3
2
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
17
20
16
18
In the current month, XNCR has received 14 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. XNCR average Analyst price target in the past 3 months is 24.30.
Each month's total comprises the sum of three months' worth of ratings.

XNCR Financial Forecast

XNCR Earnings Forecast

Next quarter’s earnings estimate for XNCR is -$0.80 with a range of -$1.08 to -$0.40. The previous quarter’s EPS was -$1.71. XNCR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year XNCR has Performed in-line its overall industry.
Next quarter’s earnings estimate for XNCR is -$0.80 with a range of -$1.08 to -$0.40. The previous quarter’s EPS was -$1.71. XNCR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year XNCR has Performed in-line its overall industry.

XNCR Sales Forecast

Next quarter’s sales forecast for XNCR is $18.23M with a range of $2.84M to $40.00M. The previous quarter’s sales results were $4.52M. XNCR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year XNCR has Performed in-line its overall industry.
Next quarter’s sales forecast for XNCR is $18.23M with a range of $2.84M to $40.00M. The previous quarter’s sales results were $4.52M. XNCR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year XNCR has Performed in-line its overall industry.

XNCR Stock Forecast FAQ

What is XNCR’s average 12-month price target, according to analysts?
Based on analyst ratings, Xencor Inc.’s 12-month average price target is 24.30.
    What is XNCR’s upside potential, based on the analysts’ average price target?
    Xencor Inc. has 86.06% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is XNCR a Buy, Sell or Hold?
          Xencor Inc. has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Xencor Inc.’s price target?
            The average price target for Xencor Inc. is 24.30. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $38.00 ,the lowest forecast is $13.00. The average price target represents 86.06% Increase from the current price of $13.06.
              What do analysts say about Xencor Inc.?
              Xencor Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of XNCR?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.